PropThink: In-Line Earnings Are Good Enough For More QCOR Upside

[ACN Newswire] – By David MoskowitzQuestcor Pharmaceuticals (NASDAQ:QCOR) is scheduled to report third quarter earnings Tuesday after the market closes, and the Wall Street Consensus expects revenues (mostly Acthar Gel) … more

View todays social media effects on QCOR

View the latest stocks trending across Twitter. Click to view dashboard